| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.36B | +8.3% |
| R&D Expense | $143.0M | +0.0% |
| SG&A Expense | $3.11B | -2.6% |
| Operating Income | $5.37B | +7.7% |
| Interest Expense | $277.0M | +259.7% |
| Pre-tax Income | $5.54B | +8.7% |
| Income Tax | $1.43B | +13.6% |
| Net Income | $4.15B | +8.4% |
| EPS (Basic) | $8.30 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.44B | +92.6% |
| Accounts Receivable | $4.56B | +1.3% |
| Inventory | $1.98B | +14.1% |
| Current Assets | $13.05B | +28.4% |
| Total Assets | $79.66B | -2.4% |
| Current Liabilities | $16.48B | +20.8% |
| Long-term Debt | $13.80B | +5.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.86B | -8.9% |
| Capital Expenditures | $3.17B | +2.8% |
| Investing Cash Flow | -$3.09B | -2.7% |
| Financing Cash Flow | -$3.09B | +59.3% |
| Free Cash Flow | $5.69B | -14.3% |
| +12.2% |
| EPS (Diluted) | $8.23 | +12.3% |
| Total Liabilities |
| $38.27B |
| +5.8% |
| Stockholders' Equity | $40.03B | -9.1% |